Efficacy and Safety Data of Osimertinib in Elderly Patients with NSCLC Who Harbor the EGFR T790M Mutation After Failure of Initial EGFR-TKI Treatment
about
Efficacy and Safety Data of Osimertinib in Elderly Patients with NSCLC Who Harbor the EGFR T790M Mutation After Failure of Initial EGFR-TKI Treatment
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Efficacy and Safety Data of Os ...... of Initial EGFR-TKI Treatment
@en
type
label
Efficacy and Safety Data of Os ...... of Initial EGFR-TKI Treatment
@en
prefLabel
Efficacy and Safety Data of Os ...... of Initial EGFR-TKI Treatment
@en
P2093
P356
P1433
P1476
Efficacy and Safety Data of Os ...... of Initial EGFR-TKI Treatment
@en
P2093
Hiroaki Kuroda
Hiromi Furuta
Junichi Shimizu
Makiko Kobara
Naohiro Watanabe
Takehiro Uemura
Tatsuya Yoshida
Teppei Yamaguchi
Toyoaki Hida
Yoshitsugu Horio
P304
P356
10.21873/ANTICANRES.12847
P577
2018-09-01T00:00:00Z